New Drugs

Brand/Generic Company Description
Cabenuva
cabotegravir and rilpivirine
Click here for more information
ViiV Healthcare

A co-packaged injectable integrase strand transfer inhibitor and non-nucleoside reverse transcriptase inhibitor for HIV-1 infection.

Cosela
trilaciclib
Click here for more information
G1 Therapeutics

A kinase inhibitor to decrease the incidence of chemotherapy-induced myelosuppression.

Evkeeza
evinacumab-dgnb
Click here for more information
Regeneron

A monoclonal antibody for homozygous familial hypercholesterolemia.

Lupkynis
voclosporin
Click here for more information
Aurinia Pharm.

A calcineurin-inhibitor immunosuppressant for active lupus nephritis.

Tepmetko
tepotinib
Click here for more information
EMD Serono

A kinase inhibitor for metastatic non-small cell lung cancer.

Ukoniq
umbralisib
Click here for more information
TG Therapeutics

A kinase inhibitor for marginal zone lymphoma and follicular lymphoma.

Verquvo
vericiguat
Click here for more information
Merck

A guanylate cyclase stimulator for patients with symptomatic chronic heart failure and ejection fraction <45%.

Vocabria
cabotegravir
Click here for more information
ViiV Healthcare

An HIV-1 integrase strand transfer inhibitor for short-term treatment of HIV-1 infection.

Brand/Generic Company Description
Posimir
bupivacaine
Click here for more information
Durect Corp.

New formulation local anesthetic for infiltration use.

Brand/Generic Company Description